Saturday, November 21, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Medicine

Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model

November 21, 2026
in Medicine
Kristina Jarvis
By Kristina Jarvis Scienmag Editorial Profile - Infectious Disease Medicine
Reading Time: 3 mins read
0
Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model

Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Researchers at the University of Maryland School of Medicine and the Institute of Human Virology have established the first successful human challenge model for dengue virus serotype 4. The experimental clinical model is designed to facilitate and accelerate the evaluation of candidate vaccines and targeted antiviral therapeutics against a viral strain that has historically posed persistent barriers to scientific study. Findings detailing the phase 1 dose optimisation and homologous rechallenge trial were published in The Lancet Microbe.

Dengue is a mosquito-borne flavivirus comprising four antigenically distinct serotypes designated DENV-1 through DENV-4. Dengue serotype 4 represents a unique public health and research hurdle because it circulates slowly and unpredictably, frequently with decades elapsing between recognized community outbreaks. Consequently, conventional large-scale field efficacy trials have encountered difficulties assessing vaccine performance, leaving recent phase 3 clinical trials unable to generate reliable efficacy estimates for this specific strain.

Conducted in Baltimore between April 2022 and December 2023, the study evaluated healthy adult volunteers to establish viral dynamics and clinical safety parameters. Participants received a single subcutaneous injection containing 95 plaque-forming units of the live challenge virus.

Following inoculation, volunteers were closely monitored under strict biosafety and containment precautions to prevent secondary environmental transmission. Participants underwent daily clinical assessments for emergent symptoms and had regular blood collections to measure viral kinetics. To ensure local mosquito populations could not acquire the virus and transmit it within the community, all study participants were accommodated in a local hotel during the window in which active virus remained detectable in their peripheral blood.

All 14 enrolled participants subsequently developed detectable viremia alongside mild-to-moderate dengue symptoms. Clinical manifestations followed a consistent presentation across the cohort, with rash and fatigue developing in every participant, followed in frequency by headaches.

To map immune mechanisms comprehensively, investigators paired clinical tracking with longitudinal immunological and transcriptomic profiling. After the initial viral challenge, participants mounted robust primary immune defenses characterized by significant antibody responses, marked expansion of antibody-producing cells, and widespread upregulation of antiviral genes.

The newly validated platform builds upon previous clinical models previously developed for dengue serotypes 1 and 3, forming part of a broader consortium effort focused on establishing human challenge frameworks for all four circulating serotypes.

Although the trial was conducted in a relatively small cohort of healthy adult volunteers and requires further validation, the established model provides a critical clinical foundation for ongoing flavivirus countermeasure research.

According to study principal investigator Kirsten E. Lyke, MD, Professor of Medicine at the Center for Vaccine Development and Global Health, the dengue virus ranks among the World Health Organization’s top ten global health threats. Lyke cautioned that a recent outbreak in Florida represents only an initial harbinger of the geographic spread of dengue projected to occur across the United States by 2080. Because medical science currently has no approved antiviral therapy to treat dengue infection, developing preventative vaccines remains critically important for protecting human populations both immediately and over the coming decades.

Lyke highlighted that controlled infection models allow investigators to test therapeutics, biologic agents, and vaccines in people so that researchers can focus energy and resources on advancing products with confirmed efficacy.

The phase 1 dose optimisation and homologous rechallenge trial was funded by the Military Infectious Disease Research Program and the Medical Technology Enterprise Consortium.

Subject of Research: Development of a human challenge model for dengue virus serotype 4

Article Title: University of Maryland School of Medicine researchers develop new human challenge model to advance dengue vaccine and treatment research

Article References: University of Maryland School of Medicine researchers develop new human challenge model to advance dengue vaccine and treatment research. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Dengue virus, DENV-4, Human challenge model, Flavivirus, Vaccine development, Antiviral therapeutics, The Lancet Microbe, University of Maryland School of Medicine, Institute of Human Virology, Infectious diseases, Mosquito-borne illness, Clinical trials, Dose optimisation, Homologous rechallenge, Viral kinetics, Antibody response, Transcriptomic analysis, Immune protection

Cite Scienmag News

Kristina Jarvis. (November 21, 2026). Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model. Scienmag. https://scienmag.com/researchers-develop-first-dengue-serotype-4-controlled-human-challenge-model/

Kristina Jarvis. "Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model." Scienmag, 21 November 2026, https://scienmag.com/researchers-develop-first-dengue-serotype-4-controlled-human-challenge-model/. Accessed 21 November 2026.

Kristina Jarvis. "Researchers Develop First Dengue Serotype 4 Controlled Human Challenge Model." Scienmag. November 21, 2026. https://scienmag.com/researchers-develop-first-dengue-serotype-4-controlled-human-challenge-model/

Tags: antibody responseantiviral therapeuticsClinical Trialsdengue virusDENV-4dose optimisationflavivirusHomologous rechallengeHuman challenge modelImmune protectioninfectious diseasesInstitute of Human VirologyMosquito-borne illnessThe Lancet Microbetranscriptomic analysisUniversity of Maryland School of MedicineVaccine developmentviral kinetics
Share26Tweet16
Previous Post

Pretangle Tau Accrual in Default Mode Network Hubs Correlates with Cognitive Decline

Next Post

Complex Knowledge Graphs Improve Hypothesis Generation for Alzheimer’s Disease Literature Discovery

Related Posts

Large Psoriasis Study Identifies 125 Risk Loci and Pinpoints New Therapeutic Targets
Medicine

Large Psoriasis Study Identifies 125 Risk Loci and Pinpoints New Therapeutic Targets

November 21, 2026
Colorectal Cancer Review Evaluates Targeted Combinations and Dynamic Molecular Resistance Monitoring
Medicine

Colorectal Cancer Review Evaluates Targeted Combinations and Dynamic Molecular Resistance Monitoring

November 21, 2026
Elevated Progranulin Genetically Links to Lower Risk of Alzheimer’s Disease
Medicine

Elevated Progranulin Genetically Links to Lower Risk of Alzheimer’s Disease

November 21, 2026
Lysosomal Proteases Degrade Amyloid Precursor Protein and Accelerate Tau Breakdown in Laboratory Models
Medicine

Lysosomal Proteases Degrade Amyloid Precursor Protein and Accelerate Tau Breakdown in Laboratory Models

November 21, 2026
Serum MicroRNA Signature Accurately Identifies Diffuse Intrinsic Pontine Glioma in Pediatric Cohort
Medicine

Serum MicroRNA Signature Accurately Identifies Diffuse Intrinsic Pontine Glioma in Pediatric Cohort

November 21, 2026
Low Body Mass Index Linked to Contralateral Vocal Cord Paralysis After Hemithyroidectomy
Medicine

Low Body Mass Index Linked to Contralateral Vocal Cord Paralysis After Hemithyroidectomy

November 21, 2026
Next Post
Complex Knowledge Graphs Improve Hypothesis Generation for Alzheimer’s Disease Literature Discovery

Complex Knowledge Graphs Improve Hypothesis Generation for Alzheimer's Disease Literature Discovery

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Hydrothermal Exposure Reduces Carbon-Epoxy Composite Bending Strength and Accelerates Wear
  • Large Psoriasis Study Identifies 125 Risk Loci and Pinpoints New Therapeutic Targets
  • Paradoxical Leadership Links to Preschool Teacher Innovation Through Psychological Capital
  • Colorectal Cancer Review Evaluates Targeted Combinations and Dynamic Molecular Resistance Monitoring

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,151 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading